Landscapes / Targets

CD47

15 drugs act on CD47, in 30 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs15

DrugHow it worksCompanyStageNext dateDetails
Monoclonal antibody
Akeso · Public 9926.HK
Phase 3 30 Dec 2026Phase 2 trial completes
IMC002not checked
—
Phase 3 31 May 2027Phase 3 trial completes
—
Phase 2 1 Apr 2027Phase 2 trial completes
Receptor molecules, native or modified
Sanofi · Public SNY
Phase 1/2 13 Sep 2027Phase 1/2 trial completes
Receptor molecules, native or modified
Phase 2 Dec 2027Phase 2 trial completes
—
Phase 1/2 31 Dec 2027Phase 1/2 trial completes
Multi-specific immunoglobulin
Phase 1/2 Dec 2027Phase 1/2 trial completes
Multi-specific immunoglobulin
Phase 1/2 Dec 2027Phase 1/2 trial completes
—
Phase 1/2 1 Jan 2028Phase 1/2 trial completes
—
ImmuneOnco · Public 1541.HK
Phase 1/2 Feb 2029Phase 1/2 trial completes
—
Phase 1 30 Jun 2027Phase 1 trial completes
—
Phase 1 30 Dec 2027Phase 1 trial completes
—
3SBio · Public 1530.HK
Phase 1 30 Mar 2028Phase 1 trial completes
Receptor molecules, native or modified
Pfizer · Public PFE
Phase 1 —
TQB2928not checked
—
Phase 1 —

About this list

Checked
13 of 15 drugs. The other 2 are marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow CD47

Following is part of Solo: you see every change to CD47 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in